Milosz Wilczynski - Search Results

Year	Number of Results
2014	2
2015	2
2016	3
2017	2
2018	6
2019	1
2020	2
2021	3
2022	5
2023	3
2024	2

1

Personalization of Therapy in High-Grade Serous Tubo-Ovarian Cancer-The Possibility or the Necessity?

Wilczyński J, Paradowska E, Wilczyński M. Wilczyński J, et al. Among authors: wilczynski m. J Pers Med. 2023 Dec 29;14(1):49. doi: 10.3390/jpm14010049. J Pers Med. 2023. PMID: 38248751 Free PMC article. Review.

2

Endometriosis Stem Cells as a Possible Main Target for Carcinogenesis of Endometriosis-Associated Ovarian Cancer (EAOC).

Wilczyński JR, Szubert M, Paradowska E, Wilczyński M. Wilczyński JR, et al. Among authors: wilczynski m. Cancers (Basel). 2022 Dec 24;15(1):111. doi: 10.3390/cancers15010111. Cancers (Basel). 2022. PMID: 36612107 Free PMC article. Review.

3

Prediction of Chemoresistance-How Preclinical Data Could Help to Modify Therapeutic Strategy in High-Grade Serous Ovarian Cancer.

Wilczyński J, Paradowska E, Wilczyńska J, Wilczyński M. Wilczyński J, et al. Among authors: wilczynski m. Curr Oncol. 2023 Dec 29;31(1):229-249. doi: 10.3390/curroncol31010015. Curr Oncol. 2023. PMID: 38248100 Free PMC article. Review.

4

Cancer Stem Cells in Ovarian Cancer-A Source of Tumor Success and a Challenging Target for Novel Therapies.

Wilczyński JR, Wilczyński M, Paradowska E. Wilczyński JR, et al. Among authors: wilczynski m. Int J Mol Sci. 2022 Feb 24;23(5):2496. doi: 10.3390/ijms23052496. Int J Mol Sci. 2022. PMID: 35269636 Free PMC article. Review.

5

High-Grade Serous Ovarian Cancer-A Risk Factor Puzzle and Screening Fugitive.

Wilczyński J, Paradowska E, Wilczyński M. Wilczyński J, et al. Among authors: wilczynski m. Biomedicines. 2024 Jan 19;12(1):229. doi: 10.3390/biomedicines12010229. Biomedicines. 2024. PMID: 38275400 Free PMC article. Review.

6

"DEPHENCE" system-a novel regimen of therapy that is urgently needed in the high-grade serous ovarian cancer-a focus on anti-cancer stem cell and anti-tumor microenvironment targeted therapies.

Wilczyński JR, Wilczyński M, Paradowska E. Wilczyński JR, et al. Among authors: wilczynski m. Front Oncol. 2023 Jun 28;13:1201497. doi: 10.3389/fonc.2023.1201497. eCollection 2023. Front Oncol. 2023. PMID: 37448521 Free PMC article. Review.

7

A body shape index (ABSI) and endometrial pathology.

Wilczyński M, Domańska-Senderowska D, Kassassir-Ćwiklak SA, Janas Ł, Malinowski A, Wilczyński JR. Wilczyński M, et al. Women Health. 2021 Mar;61(3):313-321. doi: 10.1080/03630242.2021.1881697. Epub 2021 Feb 8. Women Health. 2021. PMID: 33550945

8

Analysis of lncRNA sequences: FAM3D-AS1, LINC01230, LINC01315 and LINC01468 in endometrial cancer.

Bieńkiewicz J, Romanowicz H, Szymańska B, Domańska-Senderowska D, Wilczyński M, Stepowicz A, Malinowski A, Smolarz B. Bieńkiewicz J, et al. Among authors: wilczynski m. BMC Cancer. 2022 Mar 29;22(1):343. doi: 10.1186/s12885-022-09426-2. BMC Cancer. 2022. PMID: 35351056 Free PMC article.

9

Supracervical hysterectomy - the vaginal route.

Wilczyński M, Cieślak J, Malinowski A. Wilczyński M, et al. Wideochir Inne Tech Maloinwazyjne. 2014 Jun;9(2):207-12. doi: 10.5114/wiitm.2014.41633. Epub 2014 Apr 1. Wideochir Inne Tech Maloinwazyjne. 2014. PMID: 25097688 Free PMC article.

10

[Rectovaginal endometriosis--analysis of 160 cases].

Wilczyński M, Wiecka-Płusa M, Antosiak B, Maciołek-Blewniewska G, Majchrzak-Baczmańska D, Malinowski A. Wilczyński M, et al. Ginekol Pol. 2015 Dec;86(12):896-901. doi: 10.17772/gp/59274. Ginekol Pol. 2015. PMID: 26995938 Polish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

29 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Results by year